SCHEDULE: Aimei Health Technology Schedule 13G Filing

W. R. Berkley Corporation and Berkley Insurance Company have filed a Schedule 13G, reporting 0% beneficial ownership of Aimei Health Technology Co., Ltd. ordinary shares.

Summary

• W. R. Berkley Corporation and its subsidiary, Berkley Insurance Company, have filed an amendment to their Schedule 13G filing.
• This filing indicates that as of June 30, 2026, they beneficially own 0 shares of Aimei Health Technology Co., Ltd. ordinary shares.
• Consequently, their ownership percentage is reported as 0.0%.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a neutral filing, primarily administrative in nature with no new financial information or strategic shifts.

Negatives

• The filing confirms a complete lack of beneficial ownership of Aimei Health Technology Co., Ltd. ordinary shares by W. R. Berkley Corporation and Berkley Insurance Company.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. This filing, reporting 0% ownership, suggests a change in reporting status or a correction, rather than a new investment or divestment.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Securities Exchange Act, Aimei Health Technology